Gravitational waves from inspiralling compact binaries: Energy flux to third post-Newtonian order

The multipolar-post-Minkowskian approach to gravitational radiation is applied to the problem of the generation of waves by the compact binary inspiral. We investigate specifically the third post-Newtonian (3PN) approximation in the total energy flux. The new results are the computation of the mass quadrupole moment of the binary to the 3PN order, and the current quadrupole and mass octupole to the 2PN order. Wave tails and tails of tails in the far zone are included up to the 3.5PN order. The recently derived 3PN equations of binary motion are used to compute the time-derivatives of the moments. We find perfect agreement to the 3.5PN order with perturbation calculations of black holes in the test-mass limit for one body. Technical inputs in our computation include a model of point particles for describing the compact objects, and the Hadamard self-field regularization. Because of a physical incompleteness of the Hadamard regularization at the 3PN order, the energy flux depends on one unknown physical parameter, which is a combination of a parameter \lambda in the equations of motion, and a new parameter \theta coming from the quadrupole moment.Comment: 69 pages, version which includes the correction of an Erratum to be published in Phys. Rev. D (2005

Gravitational-Wave Inspiral of Compact Binary Systems to 7/2 Post-Newtonian Order

The inspiral of compact binaries, driven by gravitational-radiation reaction, is investigated through 7/2 post-Newtonian (3.5PN) order beyond the quadrupole radiation. We outline the derivation of the 3.5PN-accurate binary's center-of-mass energy and emitted gravitational flux. The analysis consistently includes the relativistic effects in the binary's equations of motion and multipole moments, as well as the contributions of tails, and tails of tails, in the wave zone. However the result is not fully determined because of some physical incompleteness, present at the 3PN order, of the model of point-particle and the associated Hadamard-type self-field regularization. The orbital phase, whose prior knowledge is crucial for searching and analyzing the inspiral signal, is computed from the standard energy balance argument.Comment: 12 pages, version which includes the correction of an Erratum to be published in Phys. Rev. D (2005

Measuring gravitational effects on antimatter in space

A direct measurement of the gravitational acceleration of antimatter has never been performed to date. Recently, such an experiment has been proposed, using antihydrogen with an atom interferometer and an antihydrogen confinament has been realized at CERN. In alternative we propose an experimental test of the gravitational interaction with antimatter by measuring the branching fraction of the CP violating decay of KL in space. In fact, even if the theoretical Standard Model explains the CPV with the presence of pure phase in the KMC Kobaiashi-Maskava-Cabibbo matrix, ample room is left for contributions by other interactions and forces to generate CPV in the mixing of the neutral K and B mesons. Gravitation is a good candidate and we show that at the altitude of the International Space Station, gravitational effects may change the level of CP violation such that a 5 sigma discrimination may be obtained by collecting the KL produced by the cosmic proton flux within a few years

Recent discovery of Paranthura japonica Richardson, 1909 (Crustacea: Isopod: Paranthuridae) in European marine waters (Arcachon Bay, Bay of Biscay)

The Asiatic isopod Paranthura japonica Richardson, 1909 was collected in 2007 in Arcachon Bay (SW France), where the species occurs in a variety of habitats, both in the intertidal and at shallow depths. This species, native to the Sea of Japan, may have been accidentally introduced in Arcachon Bay with oyster transfers or as fouling on ship hulls

Reconciling MOND and dark matter?

Observations of galaxies suggest a one-to-one analytic relation between the inferred gravity of dark matter at any radius and the enclosed baryonic mass, a relation summarized by Milgrom's law of modified Newtonian dynamics (MOND). However, present-day covariant versions of MOND usually require some additional fields contributing to the geometry, as well as an additional hot dark matter component to explain cluster dynamics and cosmology. Here, we envisage a slightly more mundane explanation, suggesting that dark matter does exist but is the source of MOND-like phenomenology in galaxies. We assume a canonical action for dark matter, but also add an interaction term between baryonic matter, gravity, and dark matter, such that standard matter effectively obeys the MOND field equation in galaxies. We show that even the simplest realization of the framework leads to a model which reproduces some phenomenological predictions of cold dark matter (CDM) and MOND at those scales where these are most successful. We also devise a more general form of the interaction term, introducing the medium density as a new order parameter. This allows for new physical effects which should be amenable to observational tests in the near future. Hence, this very general framework, which can be furthermore related to a generalized scalar-tensor theory, opens the way to a possible unification of the successes of CDM and MOND at different scales.Comment: 9 page

Population Pharmacokinetics of Palbociclib and Its Correlation with Clinical Efficacy and Safety in Patients with Advanced Breast Cancer.

Neutropenia is the most frequent dose-limiting toxicity reported in patients with metastatic breast cancer receiving palbociclib. The objective of this study was to investigate the pharmacokinetic-pharmacodynamic (PK/PD) relationships for toxicity (i.e., absolute neutrophil count, ANC) and efficacy (i.e., progression-free survival, PFS). A semi-mechanistic PK/PD model was used to predict neutrophils' time course using a population approach (NONMEM). Influence of demographic and clinical characteristics was evaluated. Cox proportional hazards models were developed to evaluate the influence of palbociclib PK on PFS. A two-compartment model with first-order absorption and a lag time adequately described the 255 palbociclib concentrations provided by 44 patients. The effect of the co-administration of proton-pump inhibitors in fasting conditions increased palbociclib clearance by 56%. None of the tested covariates affected the PD parameters. Model-based simulations confirmed the concentration-dependent and non-cumulative properties of palbociclib-induced neutropenia, reversible after treatment withdrawal. The ANC nadir occurred approximately at day 24 of each cycle. Cox analyses revealed a trend for better PFS with increasing palbociclib exposure in older patients. By characterizing palbociclib-induced neutropenia, this model offers support to clinicians to rationally optimize treatment management through patient-individualized strategies

Sarcopenia Predicts Early Dose-Limiting Toxicities and Pharmacokinetics of Sorafenib in Patients with Hepatocellular Carcinoma

BACKGROUND: Sorafenib induces frequent dose limiting toxicities (DLT) in patients with advanced hepatocellular carcinoma (HCC). Sarcopenia has been associated with poor performance status and shortened survival in cancer patients. PATIENTS AND METHODS: The characteristics of Child Pugh A cirrhotic patients with HCC receiving sorafenib in our institution were retrospectively analyzed. Sorafenib plasma concentrations were determined at each visit. Toxicities were recorded during the first month of treatment, and sarcopenia was determined from baseline CT-scans. RESULTS: Forty patients (30 males) were included. Eleven (27.5%) were sarcopenic. Eighteen patients (45%) experienced a DLT during the first month of treatment. Sarcopenic patients experienced significantly more DLTs than non-sarcopenic patients did (82% versus 31%, p = 0.005). Grade 3 diarrhea was significantly more frequent in sarcopenic patients than in non-sarcopenic patients (45.5% versus 6.9%, p = 0.01), but not grade 3 hand foot syndrome reaction (9% versus 17.2%, p = 1). On day 28, median sorafenib AUC (n = 17) was significantly higher in sarcopenic patients (102.4 mg/l.h versus 53.7 mg/l.h, p = 0.013). CONCLUSIONS: Among cirrhotic Child Pugh A patients with advanced HCC, sarcopenia predicts sorafenib exposure and the occurrence of DLT within the first month of treatment

The Benefits Conferred by Radial Access for Cardiac Catheterization Are Offset by a Paradoxical Increase in the Rate of Vascular Access Site Complications With Femoral Access The Campeau Radial Paradox

AbstractObjectivesThe purpose of this study was to assess whether the benefits conferred by radial access (RA) at an individual level are offset by a proportionally greater incidence of vascular access site complications (VASC) at a population level when femoral access (FA) is performed.BackgroundThe recent widespread adoption of RA for cardiac catheterization has been associated with increased rates of VASCs when FA is attempted.MethodsLogistic regression was used to calculate the adjusted VASC rate in a contemporary cohort of consecutive patients (2006 to 2008) where both RA and FA were used, and compared it with the adjusted VASC rate observed in a historical control cohort (1996 to 1998) where only FA was used. We calculated the adjusted attributable risk to estimate the proportion of VASC attributable to the introduction of RA in FA patients of the contemporary cohort.ResultsA total of 17,059 patients were included. At a population level, the VASC rate was higher in the overall contemporary cohort compared with the historical cohort (adjusted rates: 2.91% vs. 1.98%; odds ratio [OR]: 1.48, 95% confidence interval [CI]: 1.17 to 1.89; p = 0.001). In the contemporary cohort, RA patients experienced fewer VASC than FA patients (adjusted rates: 1.44% vs. 4.19%; OR: 0.33, 95% CI: 0.23 to 0.48; p < 0.001). We observed a higher VASC rate in FA patients in the contemporary cohort compared with the historical cohort (adjusted rates: 4.19% vs. 1.98%; OR: 2.16, 95% CI: 1.67 to 2.81; p < 0.001). This finding was consistent for both diagnostic and therapeutic catheterizations separately. The proportion of VASCs attributable to RA in the contemporary FA patients was estimated at 52.7%.ConclusionsIn a contemporary population where both RA and FA were used, the safety benefit associated with RA is offset by a paradoxical increase in VASCs among FA patients. The existence of this radial paradox should be taken into consideration, especially among trainees and default radial operators

Reversible Decrease of Portal Venous Flow in Cirrhotic Patients: A Positive Side Effect of Sorafenib

Portal hypertension, the most important complication with cirrhosis of the liver, is a serious disease. Sorafenib, a tyrosine kinase inhibitor is validated in advanced hepatocellular carcinoma. Because angiogenesis is a pathological hallmark of portal hypertension, the goal of our study was to determine the effect of sorafenib on portal venous flow and portosystemic collateral circulation in patients receiving sorafenib therapy for advanced hepatocellular carcinoma. Porto-collateral circulations were evaluated using a magnetic resonance technique prior sorafenib therapy, and at day 30. All patients under sorafenib therapy had a decrease in portal venous flow of at least 36%. In contrast, no specific change was observed in the azygos vein or the abdominal aorta. No portal venous flow modification was observed in the control group. Sorafenib is the first anti-angiogenic therapy to demonstrate a beneficial and reversible decrease of portal venous flow among cirrhotic patients